Drugs / MRX-8
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04649541 Comparator | Nov 2020 → Dec 2021 | — | MicuRx | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRX-8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04649541 ↗ |
| Route | Intravenous | “single and multiple intravenous (IV) doses of MRX-8” NCT04649541 ↗ |